The third dimension: new developments in cell culture models for colorectal research

Cellular and Molecular Life Sciences

Volumn 73, Issue 21, 2016, Pages 3971-3989

  Pereira, Joana F S ^a,b   Awatade, Nikhil T ^b   Loureiro, Cláudia A ^a,b   Matos, Paulo ^a,b   Amaral, Margarida D ^b   Jordan, Peter ^a,b  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

3D culture; Cell culture model; Cell polarization; Cell spheroids; Colon; Colorectal cancer; Cystic fibrosis; Epithelial chloride transport; Inflammatory bowel disease; Organoids; Small intestine

Indexed keywords

MATRIGEL;

CACO 2 CELL LINE; CELL CULTURE; CELL LINE; COCULTURE; COLORECTAL CARCINOMA; CYTOPLASM; DIAGNOSTIC TEST; DIGESTIVE FUNCTION; EPITHELIUM; EX VIVO STUDY; HUMAN; HYDROGEL; INTESTINE CELL; MEMBRANE FILTER; NONHUMAN; PATHOPHYSIOLOGY; POLARIZATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE TECHNIQUE; CHEMISTRY; COLON; CYTOLOGY; MEDICAL RESEARCH; PROCEDURES; RECTUM; TISSUE SCAFFOLD;

ANIMALS; BIOMEDICAL RESEARCH; CELL CULTURE TECHNIQUES; CELL LINE; COLON; HUMANS; MODELS, BIOLOGICAL; RECTUM; TISSUE SCAFFOLDS;

EID: 84965029370     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-016-2258-2     Document Type: Review

References (173)

1. Zhang K, Hornef MW, Dupont A (2015) The intestinal epithelium as guardian of gut barrier integrity: the epithelium as a barrier to infection. Cell Microbiol 17:1561–1569. doi:10.1111/cmi.12501
2. Radtke F, Clevers H (2005) Self-renewal and cancer of the gut: two sides of a coin. Science 307:1904–1909. doi:10.1126/science.1104815
3. Sambuy Y, De Angelis I, Ranaldi G et al (2005) The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21:1–26. doi:10.1007/s10565-005-0085-6
4. Liang GH, Weber CR (2014) Molecular aspects of tight junction barrier function. Curr Opin Pharmacol 19:84–89. doi:10.1016/j.coph.2014.07.017
5. Suzuki T (2013) Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci CMLS 70:631–659. doi:10.1007/s00018-012-1070-x
6. De Bosscher K, Hill CS, Nicolás FJ (2004) Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells. Biochem J 379:209–216. doi:10.1042/BJ20031886
7. Forbes SA, Bindal N, Bamford S et al (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39:D945–D950. doi:10.1093/nar/gkq929
8. Vachon PH, Beaulieu JF (1992) Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line. Gastroenterology 103:414–423
9. Vachon PH, Perreault N, Magny P, Beaulieu JF (1996) Uncoordinated, transient mosaic patterns of intestinal hydrolase expression in differentiating human enterocytes. J Cell Physiol 166:198–207. doi:10.1002/(SICI)1097-4652(199601)166:1<198:AID-JCP21>3.0.CO;2-A
10. Kim HJ, Ingber DE (2013) Gut-on-a-chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr Biol Quant Biosci Nano Macro 5:1130–1140. doi:10.1039/c3ib40126j
11. Meunier V, Bourrié M, Berger Y, Fabre G (1995) The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol 11:187–194
12. Peterson MD, Mooseker MS (1992) Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J Cell Sci 102(Pt 3):581–600
13. des Rieux A, Fievez V, Théate I et al (2007) An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells. Eur J Pharm Sci Off J Eur Fed Pharm Sci 30:380–391. doi:10.1016/j.ejps.2006.12.006
14. Gullberg E, Leonard M, Karlsson J et al (2000) Expression of specific markers and particle transport in a new human intestinal M-cell model. Biochem Biophys Res Commun 279:808–813. doi:10.1006/bbrc.2000.4038
15. Kerneis S (1997) Conversion by Peyer’s patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 277:949–952. doi:10.1126/science.277.5328.949
16. Corr SC, Gahan CCGM, Hill C (2008) M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol Med Microbiol 52:2–12. doi:10.1111/j.1574-695X.2007.00359.x
17. Niedergang F, Kraehenbuhl JP (2000) Much ado about M cells. Trends Cell Biol 10:137–141
18. Brayden DJ, Jepson MA, Baird AW (2005) Keynote review: intestinal Peyer’s patch M cells and oral vaccine targeting. Drug Discov Today 10:1145–1157. doi:10.1016/S1359-6446(05)03536-1
19. Lai YH, D’Souza MJ (2008) Microparticle transport in the human intestinal M cell model. J Drug Target 16:36–42. doi:10.1080/10611860701639848
20. Ahmed D, Eide PW, Eilertsen IA et al (2013) Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis 2:e71. doi:10.1038/oncsis.2013.35
21. Mouradov D, Sloggett C, Jorissen RN et al (2014) Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. Cancer Res 74:3238–3247. doi:10.1158/0008-5472.CAN-14-0013
22. Chaudhuri O, Koshy ST, Branco da Cunha C et al (2014) Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium. Nat Mater 13:970–978. doi:10.1038/nmat4009
23. Pickup MW, Mouw JK, Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15:1243–1253. doi:10.15252/embr.201439246
24. Tung JC, Barnes JM, Desai SR et al (2015) Tumor mechanics and metabolic dysfunction. Free Radic Biol Med 79:269–280. doi:10.1016/j.freeradbiomed.2014.11.020
25. Owen KA, Abshire MY, Tilghman RW et al (2011) FAK regulates intestinal epithelial cell survival and proliferation during mucosal wound healing. PLoS One 6:e23123. doi:10.1371/journal.pone.0023123
26. Nukuda A, Sasaki C, Ishihara S et al (2015) Stiff substrates increase YAP-signaling-mediated matrix metalloproteinase-7 expression. Oncogenesis 4:e165. doi:10.1038/oncsis.2015.24
27. Dolznig H, Rupp C, Puri C et al (2011) Modeling colon adenocarcinomas in vitro a 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction. Am J Pathol 179:487–501. doi:10.1016/j.ajpath.2011.03.015
28. Goodwin TJ, Jessup JM, Wolf DA (1992) Morphologic differentiation of colon carcinoma cell lines HT-29 and HT-29KM in rotating-wall vessels. Vitro Cell Dev Biol J Tissue Cult Assoc 28A:47–60
29. Paduch R, Kandefer-Szerszeń M, Piersiak T (2010) The importance of release of proinflammatory cytokines, ROS, and NO in different stages of colon carcinoma growth and metastasis after treatment with cytotoxic drugs. Oncol Res 18:419–436
30. Straussman R, Morikawa T, Shee K et al (2012) Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487:500–504. doi:10.1038/nature11183
31. Wilson TR, Fridlyand J, Yan Y et al (2012) Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 487:505–509. doi:10.1038/nature11249
32. Fath KR, Mamajiwalla SN, Burgess DR (1993) The cytoskeleton in development of epithelial cell polarity. J Cell Sci 1993:65–73. doi:10.1242/jcs.1993.Supplement_17.10
33. Massey-Harroche D (2000) Epithelial cell polarity as reflected in enterocytes. Microsc Res Tech 49:353–362. doi:10.1002/(SICI)1097-0029(20000515)49:4<353:AID-JEMT4>3.0.CO;2-8
34. Hidalgo IJ, Raub TJ, Borchardt RT (1989) Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736–749
35. Mellman I, Nelson WJ (2008) Coordinated protein sorting, targeting and distribution in polarized cells. Nat Rev Mol Cell Biol 9:833–845. doi:10.1038/nrm2525
36. Nelson WJ (2003) Adaptation of core mechanisms to generate cell polarity. Nature 422:766–774. doi:10.1038/nature01602
37. Srinivasan B, Kolli AR, Esch MB et al (2015) TEER measurement techniques for in vitro barrier model systems. J Lab Autom 20:107–126. doi:10.1177/2211068214561025
38. Delie F, Rubas W (1997) A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst 14:221–286
39. − channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis. Gastroenterology 127:1085–1095
40. Mall M, Wissner A, Seydewitz HH et al (2000) Defective cholinergic Cl(−) secretion and detection of K(+) secretion in rectal biopsies from cystic fibrosis patients. Am J Physiol Gastrointest Liver Physiol 278:G617–G624
41. Sousa M, Servidoni MF, Vinagre AM et al (2012) Measurements of CFTR-mediated Cl- secretion in human rectal biopsies constitute a robust biomarker for Cystic Fibrosis diagnosis and prognosis. PLoS One 7:e47708. doi:10.1371/journal.pone.0047708
42. Beekman JM, Sermet-Gaudelus I, de Boeck K et al (2014) CFTR functional measurements in human models for diagnosis, prognosis and personalized therapy. J Cyst Fibros 13:363–372. doi:10.1016/j.jcf.2014.05.007
43. Botelho HM, Uliyakina I, Awatade NT et al (2015) Protein traffic disorders: an effective high-throughput fluorescence microscopy pipeline for drug discovery. Sci Rep 5:9038. doi:10.1038/srep09038
44. Duell BL, Cripps AW, Schembri MA, Ulett GC (2011) Epithelial cell coculture models for studying infectious diseases: benefits and limitations. J Biomed Biotechnol 2011:852419. doi:10.1155/2011/852419
45. Benam KH, Dauth S, Hassell B et al (2015) Engineered in vitro disease models. Annu Rev Pathol Mech Dis 10:195–262. doi:10.1146/annurev-pathol-012414-040418
46. Huh D, Kim HJ, Fraser JP et al (2013) Microfabrication of human organs-on-chips. Nat Protoc 8:2135–2157. doi:10.1038/nprot.2013.137
47. Huh D, Hamilton GA, Ingber DE (2011) From 3D cell culture to organs-on-chips. Trends Cell Biol 21:745–754. doi:10.1016/j.tcb.2011.09.005
48. Kim HJ, Huh D, Hamilton G, Ingber DE (2012) Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12:2165–2174. doi:10.1039/c2lc40074j
49. Sung JH, Esch MB, Prot J-M et al (2013) Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip 13:1201–1212. doi:10.1039/c3lc41017j
50. Bellas E, Chen CS (2014) Forms, forces, and stem cell fate. Curr Opin Cell Biol 31:92–97. doi:10.1016/j.ceb.2014.09.006
51. Gasparski AN, Beningo KA (2015) Mechanoreception at the cell membrane: more than the integrins. Arch Biochem Biophys 586:20–26. doi:10.1016/j.abb.2015.07.017
52. Humphrey JD, Dufresne ER, Schwartz MA (2014) Mechanotransduction and extracellular matrix homeostasis. Nat Rev Mol Cell Biol 15:802–812. doi:10.1038/nrm3896
53. Jansen KA, Donato DM, Balcioglu HE et al (2015) A guide to mechanobiology: where biology and physics meet. Biochim Biophys Acta. doi:10.1016/j.bbamcr.2015.05.007
54. Kim HJ, Li H, Collins JJ, Ingber DE (2016) Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci 113:E7–E15. doi:10.1073/pnas.1522193112
55. Kim SH, Lee JW, Choi I et al (2013) A microfluidic device with 3-d hydrogel villi scaffold to simulate intestinal absorption. J Nanosci Nanotechnol 13:7220–7228
56. Hickman JA, Graeser R, de Hoogt R et al (2014) Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo. Biotechnol J 9:1115–1128. doi:10.1002/biot.201300492
57. Hay M, Thomas DW, Craighead JL et al (2014) Clinical development success rates for investigational drugs. Nat Biotechnol 32:40–51. doi:10.1038/nbt.2786
58. Hutchinson L, Kirk R (2011) High drug attrition rates—where are we going wrong? Nat Rev Clin Oncol 8:189–190. doi:10.1038/nrclinonc.2011.34
59. Longati P, Jia X, Eimer J et al (2013) 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer 13:95. doi:10.1186/1471-2407-13-95
60. Thoma CR, Zimmermann M, Agarkova I et al (2014) 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev 69–70:29–41. doi:10.1016/j.addr.2014.03.001
61. Achilli T-M, Meyer J, Morgan JR (2012) Advances in the formation, use and understanding of multi-cellular spheroids. Expert Opin Biol Ther 12:1347–1360. doi:10.1517/14712598.2012.707181
62. Burdett E, Kasper FK, Mikos AG, Ludwig JA (2010) Engineering tumors: a tissue engineering perspective in cancer biology. Tissue Eng Part B Rev 16:351–359. doi:10.1089/ten.TEB.2009.0676
63. Knight E, Przyborski S (2014) Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro. J Anat 227:746–756. doi:10.1111/joa.12257
64. Wang C, Tang Z, Zhao Y et al (2014) Three-dimensional in vitro cancer models: a short review. Biofabrication 6:022001. doi:10.1088/1758-5082/6/2/022001
65. Vermeulen L, Todaro M, de Sousa Mello F et al (2008) Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA 105:13427–13432. doi:10.1073/pnas.0805706105
66. Fan X, Ouyang N, Teng H, Yao H (2011) Isolation and characterization of spheroid cells from the HT29 colon cancer cell line. Int J Colorectal Dis 26:1279–1285. doi:10.1007/s00384-011-1248-y
67. + colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer 102:1265–1275. doi:10.1038/sj.bjc.6605610
68. Ashley N, Jones M, Ouaret D et al (2014) Rapidly derived colorectal cancer cultures recapitulate parental cancer characteristics and enable personalized therapeutic assays. J Pathol 234:34–45. doi:10.1002/path.4371
69. Hirschhaeuser F, Menne H, Dittfeld C et al (2010) Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol 148:3–15. doi:10.1016/j.jbiotec.2010.01.012
70. Ham SL, Atefi E, Fyffe D, Tavana H (2015) Robotic production of cancer cell spheroids with an aqueous two-phase system for drug testing. J Vis Exp JoVE. doi:10.3791/52754
71. Leung BM, Lesher-Perez SC, Matsuoka T et al (2015) Media additives to promote spheroid circularity and compactness in hanging drop platform. Biomater Sci 3:336–344. doi:10.1039/c4bm00319e
72. Friedrich J, Eder W, Castaneda J et al (2007) A reliable tool to determine cell viability in complex 3-D culture: the acid phosphatase assay. J Biomol Screen 12:925–937. doi:10.1177/1087057107306839
73. Howes AL, Chiang GG, Lang ES et al (2007) The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures. Mol Cancer Ther 6:2505–2514. doi:10.1158/1535-7163.MCT-06-0698
74. Wenzel C, Riefke B, Gründemann S et al (2014) 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions. Exp Cell Res 323:131–143. doi:10.1016/j.yexcr.2014.01.017
75. Edmondson R, Broglie JJ, Adcock AF, Yang L (2014) Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol 12:207–218. doi:10.1089/adt.2014.573
76. Tibbitt MW, Anseth KS (2009) Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 103:655–663. doi:10.1002/bit.22361
77. O’Keane JC, Kupchik HZ, Schroy PC et al (1990) A three-dimensional system for long-term culture of human colorectal adenomas. Am J Pathol 137:1539–1547
78. Buhrmann C, Shayan P, Kraehe P et al (2015) Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer. Biochem Pharmacol 98:51–68. doi:10.1016/j.bcp.2015.08.105
79. Shakibaei M, Kraehe P, Popper B et al (2015) Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer. BMC Cancer 15:250. doi:10.1186/s12885-015-1291-0
80. Rowley JA, Madlambayan G, Mooney DJ (1999) Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20:45–53
81. Bissell MJ, Kenny PA, Radisky DC (2005) Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol 70:343–356. doi:10.1101/sqb.2005.70.013
82. Bissell MJ, Hines WC (2011) Why don’t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 17:320–329. doi:10.1038/nm.2328
83. Bellis AD, Bernabé BP, Weiss MS et al (2013) Dynamic transcription factor activity profiling in 2D and 3D cell cultures. Biotechnol Bioeng 110:563–572. doi:10.1002/bit.24718
84. Correia AL, Bissell MJ (2012) The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist Updat 15:39–49. doi:10.1016/j.drup.2012.01.006
85. Rubashkin MG, Ou G, Weaver VM (2014) Deconstructing signaling in three dimensions. Biochemistry (Mosc) 53:2078–2090. doi:10.1021/bi401710d
86. Magdeldin T, López-Dávila V, Villemant C et al (2014) The efficacy of cetuximab in a tissue-engineered three-dimensional in vitro model of colorectal cancer. J Tissue Eng 5:2041731414544183. doi:10.1177/2041731414544183
87. Nyga A, Loizidou M, Emberton M, Cheema U (2013) A novel tissue engineered three-dimensional in vitro colorectal cancer model. Acta Biomater 9:7917–7926. doi:10.1016/j.actbio.2013.04.028
88. Del Buono R, Pignatelli M, Bodmer WF, Wright NA (1991) The role of the arginine-glycine-aspartic acid-directed cellular binding to type I collagen and rat mesenchymal cells in colorectal tumour differentiation. Differ Res Biol Divers 46:97–103
89. Yamamoto (1998) Overexpression of MT1-MMP is insufficient to increase experimental liver metastasis of human colon cancer cells. Int J Mol Med 22:757–761. doi:10.3892/ijmm_00000082
90. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4:33–45. doi:10.1038/nrm1004
91. Kassim YL, Tawil EAL, Lecerf D, Couteau J, Simon T, Buquet C, Vannier JP, Demange E (2014) Biomimetic three dimensional cell culturing: colorectal cancer micro-tissue engineering. J Clin Exp Oncol 3:2. doi:10.4172/2324-9110.1000123
92. Sung JH, Yu J, Luo D et al (2011) Microscale 3-D hydrogel scaffold for biomimetic gastrointestinal (GI) tract model. Lab Chip 11:389–392. doi:10.1039/C0LC00273A
93. Wang Y, Ahmad AA, Sims CE et al (2014) In vitro generation of colonic epithelium from primary cells guided by microstructures. Lab Chip 14:1622–1631. doi:10.1039/c3lc51353j
94. Benton G, Arnaoutova I, George J et al (2014) Matrigel: from discovery and ECM mimicry to assays and models for cancer research. Adv Drug Deliv Rev 79–80:3–18. doi:10.1016/j.addr.2014.06.005
95. Benton G, George J, Kleinman HK, Arnaoutova IP (2009) Advancing science and technology via 3D culture on basement membrane matrix. J Cell Physiol 221:18–25. doi:10.1002/jcp.21832
96. Hughes CS, Postovit LM, Lajoie GA (2010) Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10:1886–1890. doi:10.1002/pmic.200900758
97. Hoffman MP, Kibbey MC, Letterio JJ, Kleinman HK (1996) Role of laminin-1 and TGF-beta 3 in acinar differentiation of a human submandibular gland cell line (HSG). J Cell Sci 109(Pt 8):2013–2021
98. Weaver VM, Petersen OW, Wang F et al (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137:231–245
99. Kubota Y, Kleinman HK, Martin GR, Lawley TJ (1988) Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107:1589–1598
100. Ludwig K, Tse ES, Wang JY (2013) Colon cancer cells adopt an invasive phenotype without mesenchymal transition in 3-D but not 2-D culture upon combined stimulation with EGF and crypt growth factors. BMC Cancer 13:221. doi:10.1186/1471-2407-13-221
101. Pereira B, Sousa S, Barros R et al (2013) CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness. Nucleic Acids Res 41:3986–3999. doi:10.1093/nar/gkt087
102. Datta A, Bryant DM, Mostov KE (2011) Molecular regulation of lumen morphogenesis. Curr Biol CB 21:R126–R136. doi:10.1016/j.cub.2010.12.003
103. Yeung TM, Gandhi SC, Wilding JL et al (2010) Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci USA 107:3722–3727. doi:10.1073/pnas.0915135107
104. Luca AC, Mersch S, Deenen R et al (2013) Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One 8:e59689. doi:10.1371/journal.pone.0059689
105. Guruswamy S, Swamy MV, Choi C-I et al (2008) S-Adenosyl l-methionine inhibits azoxymethane-induced colonic aberrant crypt foci in F344 rats and suppresses human colon cancer Caco-2 cell growth in 3D culture. Int J Cancer J Int Cancer 122:25–30. doi:10.1002/ijc.23031
106. Mah AT, Van Landeghem L, Gavin HE et al (2014) Impact of diet-induced obesity on intestinal stem cells: hyperproliferation but impaired intrinsic function that requires insulin/IGF1. Endocrinology 155:3302–3314. doi:10.1210/en.2014-1112
107. Pereira C, Araújo F, Barrias CC et al (2015) Dissecting stromal-epithelial interactions in a 3D in vitro cellularized intestinal model for permeability studies. Biomaterials 56:36–45. doi:10.1016/j.biomaterials.2015.03.054
108. Cukierman E, Pankov R, Stevens DR, Yamada KM (2001) Taking cell-matrix adhesions to the third dimension. Science 294:1708–1712. doi:10.1126/science.1064829
109. Totonelli G, Maghsoudlou P, Garriboli M et al (2012) A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials 33:3401–3410. doi:10.1016/j.biomaterials.2012.01.012
110. Genovese L, Zawada L, Tosoni A et al (2014) Cellular localization, invasion, and turnover are differently influenced by healthy and tumor-derived extracellular matrix. Tissue Eng Part A 20:2005–2018. doi:10.1089/ten.TEA.2013.0588
111. Lowe SB, Tan VTG, Soeriyadi AH et al (2014) Synthesis and high-throughput processing of polymeric hydrogels for 3D cell culture. Bioconjug Chem 25:1581–1601. doi:10.1021/bc500310v
112. Trappmann B, Chen CS (2013) How cells sense extracellular matrix stiffness: a material’s perspective. Curr Opin Biotechnol 24:948–953. doi:10.1016/j.copbio.2013.03.020
113. Worthington P, Pochan DJ, Langhans SA (2015) Peptide hydrogels—versatile matrices for 3D cell culture in cancer medicine. Front Oncol 5:92. doi:10.3389/fonc.2015.00092
114. Lee J, Cuddihy MJ, Kotov NA (2008) Three-dimensional cell culture matrices: state of the art. Tissue Eng Part B Rev 14:61–86. doi:10.1089/teb.2007.0150
115. Barker N (2014) Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol 15:19–33. doi:10.1038/nrm3721
116. Barker N, van Es JH, Kuipers J et al (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449:1003–1007. doi:10.1038/nature06196
117. Jung P, Sato T, Merlos-Suárez A et al (2011) Isolation and in vitro expansion of human colonic stem cells. Nat Med 17:1225–1227. doi:10.1038/nm.2470
118. Sato T, Vries RG, Snippert HJ et al (2009) Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459:262–265. doi:10.1038/nature07935
119. Sato T, Clevers H (2013) Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 340:1190–1194. doi:10.1126/science.1234852
120. Dekkers JF, Wiegerinck CL, de Jonge HR et al (2013) A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat Med 19:939–945. doi:10.1038/nm.3201
121. Finkbeiner SR, Hill DR, Altheim CH et al (2015) Transcriptome-wide analysis reveals hallmarks of human intestine development and maturation in vitro and in vivo. Stem Cell Rep 4:1140–1155. doi:10.1016/j.stemcr.2015.04.010
122. Foulke-Abel J, In J, Yin J et al (2016) Human enteroids as a model of upper small intestinal ion transport physiology and pathophysiology. Gastroenterology. doi:10.1053/j.gastro.2015.11.047 (in press)
123. Onuma K, Ochiai M, Orihashi K et al (2013) Genetic reconstitution of tumorigenesis in primary intestinal cells. Proc Natl Acad Sci 110:11127–11132. doi:10.1073/pnas.1221926110
124. Walker NM, Liu J, Stein SR et al (2015) Cellular chloride and bicarbonate retention alters intracellular pH regulation in Cftr KO crypt epithelium. Am J Physiol Gastrointest Liver Physiol 310:G70–G80. doi:10.1152/ajpgi.00236.2015
125. Drost J, van Jaarsveld RH, Ponsioen B et al (2015) Sequential cancer mutations in cultured human intestinal stem cells. Nature 521:43–47. doi:10.1038/nature14415
126. Fujii M, Matano M, Nanki K, Sato T (2015) Efficient genetic engineering of human intestinal organoids using electroporation. Nat Protoc 10:1474–1485. doi:10.1038/nprot.2015.088
127. Sato T, Stange DE, Ferrante M et al (2011) Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology 141:1762–1772. doi:10.1053/j.gastro.2011.07.050
128. Schwank G, Koo B-K, Sasselli V et al (2013) Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13:653–658. doi:10.1016/j.stem.2013.11.002
129. Caponigro G, Sellers WR (2011) Advances in the preclinical testing of cancer therapeutic hypotheses. Nat Rev Drug Discov 10:179–187. doi:10.1038/nrd3385
130. Sachs N, Clevers H (2014) Organoid cultures for the analysis of cancer phenotypes. Curr Opin Genet Dev 24:68–73. doi:10.1016/j.gde.2013.11.012
131. van de Wetering M, Francies HE, Francis JM et al (2015) Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161:933–945. doi:10.1016/j.cell.2015.03.053
132. Spence JR, Mayhew CN, Rankin SA et al (2011) Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470:105–109. doi:10.1038/nature09691
133. Zachos NC, Kovbasnjuk O, Foulke-Abel J et al (2016) Human enteroids/colonoids and intestinal organoids functionally recapitulate normal intestinal physiology and pathophysiology. J Biol Chem. doi:10.1074/jbc.R114.635995 (in press)
134. Stange DE, Clevers H (2013) Concise review: the Yin and Yang of intestinal (cancer) stem cells and their progenitors: intestinal (Cancer) stem cells and their progenitors. Stem Cells 31:2287–2295. doi:10.1002/stem.1475
135. Kuo W-T, Lee T-C, Yang H-Y et al (2015) LPS receptor subunits have antagonistic roles in epithelial apoptosis and colonic carcinogenesis. Cell Death Differ 22:1590–1604. doi:10.1038/cdd.2014.240
136. Abbott Chalew TE, Schwab KJ (2013) Toxicity of commercially available engineered nanoparticles to Caco-2 and SW480 human intestinal epithelial cells. Cell Biol Toxicol 29:101–116. doi:10.1007/s10565-013-9241-6
137. Freeman TJ, Smith JJ, Chen X et al (2012) Smad4-mediated signaling inhibits intestinal neoplasia by Inhibiting expression of β-catenin. Gastroenterology 142(562–571):e2. doi:10.1053/j.gastro.2011.11.026
138. Hirsch D, Barker N, McNeil N et al (2014) LGR5 positivity defines stem-like cells in colorectal cancer. Carcinogenesis 35:849–858. doi:10.1093/carcin/bgt377
139. Elimrani I, Dionne S, Saragosti D et al (2015) Acetylcarnitine potentiates the anticarcinogenic effects of butyrate on SW480 colon cancer cells. Int J Oncol. doi:10.3892/ijo.2015.3029
140. Matsuda Y, Miura K, Yamane J et al (2016) SERPINI1 regulates the epithelial-mesenchymal transition in an orthotopic implantation model of colorectal cancer. Cancer Sci. doi:10.1111/cas.12909
141. Barrett KE (1993) Positive and negative regulation of chloride secretion in T84 cells. Am J Physiol 265:C859–C868
142. Dharmsathaphorn K, McRoberts JA, Mandel KG et al (1984) A human colonic tumor cell line that maintains vectorial electrolyte transport. Am J Physiol 246:G204–G208
143. Lee WY, Chin AC, Voss S, Parkos CA (2006) In vitro neutrophil transepithelial migration. Methods Mol Biol Clifton NJ 341:205–215. doi:10.1385/1-59745-113-4:205
144. McCool DJ, Marcon MA, Forstner JF, Forstner GG (1990) The T84 human colonic adenocarcinoma cell line produces mucin in culture and releases it in response to various secretagogues. Biochem J 267:491–500
145. Nataro JP, Hicks S, Phillips AD et al (1996) T84 cells in culture as a model for enteroaggregative Escherichia coli pathogenesis. Infect Immun 64:4761–4768
146. Bu X-D, Li N, Tian X-Q, Huang P-L (2011) Caco-2 and LS174T cell lines provide different models for studying mucin expression in colon cancer. Tissue Cell 43:201–206. doi:10.1016/j.tice.2011.03.002
147. Mologni L, Brussolo S, Ceccon M, Gambacorti-Passerini C (2012) Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells. PLoS One 7:e51449. doi:10.1371/journal.pone.0051449
148. van Klinken BJ, Oussoren E, Weenink JJ et al (1996) The human intestinal cell lines Caco-2 and LS174T as models to study cell-type specific mucin expression. Glycoconj J 13:757–768
149. Basu I, Mitra R, Saha PK et al (1999) Morphological and cytoskeletal changes caused by non-membrane damaging cytotoxin of Vibrio cholerae on int 407 and HeLa cells. FEMS Microbiol Lett 179:255–263
150. Canonico B, Campana R, Luchetti F et al (2014) Campylobacter jejuni cell lysates differently target mitochondria and lysosomes on HeLa cells. Apoptosis Int J Program Cell Death 19:1225–1242. doi:10.1007/s10495-014-1005-0
151. Henle G, Deinhardt F (1957) The establishment of strains of human cells in tissue culture. J Immunol Baltim Md 1950 79:54–59
152. Lacroix M (2008) Persistent use of “false” cell lines. Int J Cancer 122:1–4. doi:10.1002/ijc.23233
153. Sarem F, Sarem-Damerdji LO, Nicolas JP (1996) Comparison of the adherence of three Lactobacillus strains to Caco-2 and Int-407 human intestinal cell lines. Lett Appl Microbiol 22:439–442
154. Antunes F, Andrade F, Araújo F et al (2013) Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs. Eur J Pharm Biopharm 83:427–435. doi:10.1016/j.ejpb.2012.10.003
155. Béduneau A, Tempesta C, Fimbel S et al (2014) A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure. Eur J Pharm Biopharm 87:290–298. doi:10.1016/j.ejpb.2014.03.017
156. Chen X-M, Elisia I, Kitts DD (2010) Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design. J Pharmacol Toxicol Methods 61:334–342. doi:10.1016/j.vascn.2010.02.004
157. Hilgendorf C, Spahn-Langguth H, Regårdh CG et al (2000) Caco-2 versus caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci 89:63–75. doi:10.1002/(SICI)1520-6017(200001)89:1<63:AID-JPS7>3.0.CO;2-6
158. Johansson MEV, Ambort D, Pelaseyed T et al (2011) Composition and functional role of the mucus layers in the intestine. Cell Mol Life Sci 68:3635–3641. doi:10.1007/s00018-011-0822-3
159. Navabi N, McGuckin MA, Lindén SK (2013) Gastrointestinal cell lines form polarized epithelia with an adherent mucus layer when cultured in semi-wet interfaces with mechanical stimulation. PLoS One 8:e68761. doi:10.1371/journal.pone.0068761
160. Pontier C, Pachot J, Botham R et al (2001) HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. J Pharm Sci 90:1608–1619
161. Walter E, Janich S, Roessler BJ et al (1996) HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J Pharm Sci 85:1070–1076. doi:10.1021/js960110x
162. Lesuffleur T, Porchet N, Aubert JP et al (1993) Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations. J Cell Sci 106(Pt 3):771–783
163. Alcarraz-Vizán G, Sánchez-Tena S, Moyer MP, Cascante M (2014) Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: trichostatin A as a case study. Biochim Biophys Acta BBA Gen Subj 1840:1634–1639. doi:10.1016/j.bbagen.2013.12.024
164. Henriques A, Barros P, Moyer MP et al (2015) Expression of tumour-related Rac1b antagonizes B-Raf-induced senescence in colorectal cells. Cancer Lett 369:368–375. doi:10.1016/j.canlet.2015.08.027
165. Lea MA, Ibeh C, Shah N, Moyer MP (2007) Induction of differentiation of colon cancer cells by combined inhibition of kinases and histone deacetylase. Anticancer Res 27:741–748
166. Liu Z, Kang L, Li C et al (2014) Knockout of MIMP protein in lactobacillus plantarum lost its regulation of intestinal permeability on NCM460 epithelial cells through the zonulin pathway. BMC Gastroenterol 14:171. doi:10.1186/1471-230X-14-171
167. Liu Z, Shen T, Chen H et al (2011) Functional characterization of MIMP for its adhesion to the intestinal epithelium. Front Biosci Landmark Ed 16:2106–2127
168. Matos P, Kotelevets L, Goncalves V et al (2013) Ibuprofen inhibits colitis-induced overexpression of tumor-related Rac1b. Neoplasia 15:102–111
169. Minoo P, Moyer MP, Jass JR (2007) Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. J Pathol 212:124–133. doi:10.1002/path.2160
170. Moyer MP, Manzano LA, Merriman RL et al (1996) NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim 32:315–317
171. Sahi J, Nataraja SG, Layden TJ et al (1998) Cl- transport in an immortalized human epithelial cell line (NCM460) derived from the normal transverse colon. Am J Physiol 275:C1048–C1057
172. Schäfer H, Struck B, Feldmann E-M et al (2013) TGF-β1-dependent L1CAM expression has an essential role in macrophage-induced apoptosis resistance and cell migration of human intestinal epithelial cells. Oncogene 32:180–189. doi:10.1038/onc.2012.44
173. Zhao D, Keates AC, Kuhnt-Moore S et al (2001) Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes. J Biol Chem 276:44464–44471. doi:10.1074/jbc.M104942200